1211 Reg QT
BioCentury & Getty Images


Dec. 11 Quick Takes: FDA reveals clearer path for Entresto NDA; plus cancer group files MFN suit, Sinovac, and Merck approvals in China, aducanumab, Atox, and ImmunoGen 

Dec 12, 2020 | 2:06 AM GMT

Documents suggest FDA panel could smile on Entresto label expansion
In briefing documents released ahead of

Read the full 497 word article

How to gain access

Continue reading with a
two-week free trial.